HOME ·

03696.HK

INSILICO (03696.HK): Nominates GIPR antagonist ISM1354 as PCC
Tags：
Insilico03696.HKR&D Progress
2026-09-30
INSILICO (03696.HK): Signs AI co-development deal worth up to tens of millions of USD
Tags：
Insilico03696.HKstrategic cooperation
2026-09-21
INSILICO (03696.HK): Chairman increases shareholding by 113,500 shares, votable interest rises to approximately 8.02%
Tags：
Insilico03696.HKNewTimeSpace
2026-09-14
INSILICO (03696.HK): AI-Driven Candidate Rentosertib Completes First Patient Dosing in Phase III IPF Trial
Tags：
Insilico03696.HKR&D Progress
2026-09-10
INSILICO (03696.HK): Chairman launches share purchase plan in September, up to HKD 16 million
Tags：
Insilico03696.HKShare Increase
2026-09-04
INSILICO (03696.HK): considering participation in RMB 1.01 billion investment fund focusing on biopharma
Tags：
Insilico03696.HKInvestment
2026-08-18
INSILICO (03696.HK): to be included in MSCI Global Small Cap Index, effective after market close on 31 August
Tags：
Insilico Medicine03696.HKMSCIIndex Inclusion
2026-08-17
InSilico Medicine (03696.HK): NLRP3 Inhibitor ISM8969/HT-001 Co-Developed with Hengtai Bio Receives NMPA IND Approval for Parkinson's Disease
Tags：
Insilico03696.HK
2026-08-03
Insilico Medicine (03696.HK): ISM6331 Granted FDA Fast Track Designation for Advanced Mesothelioma Treatment
Tags：
Insilico Medicine03696.HK
2026-07-29
Empowered by HKIC's Patient Capital, Insilico Medicine (3696.HK) Enters $600 Million Global Strategic Partnership with Takeda
Tags：
Insilico03696.HKHKIC
2026-07-20
InSilico Medicine (03696.HK) and Bora Pharmaceuticals Announce Strategic Alliance with Potential Value Exceeding US$2.5 Billion
Tags：
Insilico03696.HK
2026-07-15
INSILICO (03696.HK): Enters CNS Drug R&D Collaboration with Cosmo Pharmaceutical, Potential Milestone Payments Up to Approximately RMB1.2 Billion
Tags：
Insilico03696.HKCMS00867.HKDrug Collaboration
2026-07-13
InSilico Medicine (03696.HK): Expects to Turn Profit in H1, Net Profit of US$33.5M to US$39.5M
Tags：
Insilico03696.HK
2026-07-09
INSILICO(03696.HK): Phase III Clinical Trial of Rentosertib for Idiopathic Pulmonary Fibrosis Officially Launched
Tags：
Insilico03696.HKClinical Trial
2026-07-08
Insilico Medicine (03696.HK): Strategic Partnership with Takeda for AI-Driven Drug Discovery with Total Value Up to USD 600 Million
Tags：
Insilico Medicine03696.HK
2026-07-02
Insilico Medicine (03696.HK): Two Core Senior Executives Voluntarily Extend Lock-up Period to June 2027
Tags：
Insilico Medicine03696.HK
2026-06-30
INSILICO(03696.HK) Enters AI-Powered R&D Collaboration with SK Biopharmaceuticals, Total Potential Deal Value Exceeds USD2.5 Billion
Tags：
Insilico03696.HKResearch and Development Collaboration
2026-06-22
INSILICO(03696.HK) closed 10.1% higher
Tags：
Insilico03696.HK
2026-04-22
INSILICO(03696.HK) closed 14.06% higher, The full-day turnover stood at HKD 618.6 million
Tags：
Insilico03696.HK
2026-04-20
InSilico Medicine (03696.HK) Inks AI Drug Discovery Deal Exceeding HK$931 Million Including Sales Milestones
Tags：
Insilico03696.HKAI
2026-01-27
12